BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12058044)

  • 1. Mechanism of Galpha i-mediated inhibition of type V adenylyl cyclase.
    Dessauer CW; Chen-Goodspeed M; Chen J
    J Biol Chem; 2002 Aug; 277(32):28823-9. PubMed ID: 12058044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Gialpha binding site on type V adenylyl cyclase.
    Dessauer CW; Tesmer JJ; Sprang SR; Gilman AG
    J Biol Chem; 1998 Oct; 273(40):25831-9. PubMed ID: 9748257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A guanylyl cyclase from Paramecium with 22 transmembrane spans. Expression of the catalytic domains and formation of chimeras with the catalytic domains of mammalian adenylyl cyclases.
    Linder JU; Hoffmann T; Kurz U; Schultz JE
    J Biol Chem; 2000 Apr; 275(15):11235-40. PubMed ID: 10753932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides.
    Gille A; Lushington GH; Mou TC; Doughty MB; Johnson RA; Seifert R
    J Biol Chem; 2004 May; 279(19):19955-69. PubMed ID: 14981084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenylyl cyclase regulates signal onset via the inhibitory GTP-binding protein, Gi.
    Wittpoth C; Scholich K; Bilyeu JD; Patel TB
    J Biol Chem; 2000 Aug; 275(34):25915-9. PubMed ID: 10852906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-triphosphate.
    Mou TC; Gille A; Fancy DA; Seifert R; Sprang SR
    J Biol Chem; 2005 Feb; 280(8):7253-61. PubMed ID: 15591060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases.
    Taussig R; Tang WJ; Hepler JR; Gilman AG
    J Biol Chem; 1994 Feb; 269(8):6093-100. PubMed ID: 8119955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N terminus of type 5 adenylyl cyclase scaffolds Gs heterotrimer.
    Sadana R; Dascal N; Dessauer CW
    Mol Pharmacol; 2009 Dec; 76(6):1256-64. PubMed ID: 19783621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C2 catalytic domain of adenylyl cyclase contains the second metal ion (Mn2+) binding site.
    Mitterauer T; Hohenegger M; Tang WJ; Nanoff C; Freissmuth M
    Biochemistry; 1998 Nov; 37(46):16183-91. PubMed ID: 9819210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of forskolin-insensitive to forskolin-sensitive (mouse-type IX) adenylyl cyclase.
    Yan SZ; Huang ZH; Andrews RK; Tang WJ
    Mol Pharmacol; 1998 Feb; 53(2):182-7. PubMed ID: 9463474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sites for Galpha binding on the G protein beta subunit overlap with sites for regulation of phospholipase Cbeta and adenylyl cyclase.
    Li Y; Sternweis PM; Charnecki S; Smith TF; Gilman AG; Neer EJ; Kozasa T
    J Biol Chem; 1998 Jun; 273(26):16265-72. PubMed ID: 9632686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of forskolin and ATP with the cytosolic domains of mammalian adenylyl cyclase.
    Dessauer CW; Scully TT; Gilman AG
    J Biol Chem; 1997 Aug; 272(35):22272-7. PubMed ID: 9268376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the two cytosolic domains of mammalian adenylyl cyclase.
    Whisnant RE; Gilman AG; Dessauer CW
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6621-5. PubMed ID: 8692867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations uncover a role for two magnesium ions in the catalytic mechanism of adenylyl cyclase.
    Zimmermann G; Zhou D; Taussig R
    J Biol Chem; 1998 Jul; 273(31):19650-5. PubMed ID: 9677392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulation of type 7 adenylyl cyclase by its C1b region and Escherichia coli peptidylprolyl isomerase, SlyD.
    Yan SZ; Beeler JA; Chen Y; Shelton RK; Tang WJ
    J Biol Chem; 2001 Mar; 276(11):8500-6. PubMed ID: 11113152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An important functional role of the N terminus domain of type VI adenylyl cyclase in Galphai-mediated inhibition.
    Kao YY; Lai HL; Hwang MJ; Chern Y
    J Biol Chem; 2004 Aug; 279(33):34440-8. PubMed ID: 15192109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of "P"-site-mediated inhibition of adenylyl cyclase and the requirements for substrate.
    Johnson RA; Shoshani I
    J Biol Chem; 1990 Jul; 265(20):11595-600. PubMed ID: 2365688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of adenylyl and guanylyl cyclase isoforms by the antiviral drug foscarnet.
    Kudlacek O; Mitterauer T; Nanoff C; Hohenegger M; Tang WJ; Freissmuth M; Kleuss C
    J Biol Chem; 2001 Feb; 276(5):3010-6. PubMed ID: 11050094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deterioration.
    Iwatsubo K; Minamisawa S; Tsunematsu T; Nakagome M; Toya Y; Tomlinson JE; Umemura S; Scarborough RM; Levy DE; Ishikawa Y
    J Biol Chem; 2004 Sep; 279(39):40938-45. PubMed ID: 15262973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The conserved asparagine and arginine are essential for catalysis of mammalian adenylyl cyclase.
    Yan SZ; Huang ZH; Shaw RS; Tang WJ
    J Biol Chem; 1997 May; 272(19):12342-9. PubMed ID: 9139678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.